Balaxi Pharmaceuticals Limited's market cap is currently ₹476.44M. The company's EPS TTM is ₹0.263; its P/E ratio is 11.90; Balaxi Pharmaceuticals Limited is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 21
Dec 21
Currency in INR
Balaxi Pharmaceuticals Limited Earnings and Revenue History
